Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Glatiramer acetate is approved by the Food and Drug Administration (FDA) for reducing the frequency of
relapses, but not for reducing the progression of disability. Observational studies, but not randomized
controlled trials, suggest that Glatiramer acetate may reduce progression of disability.
Glatiramer acetate is approved by the Food and Drug Administration (FDA) for reducing the frequency of
relapses, but not for reducing the progression of disability. Observational studies, but not randomized
controlled trials, suggest that Glatiramer acetate may reduce progression of disability.
Item | Test Standard | Testing Result | |
Assay | 99% | Complies | |
Apperence | White Powder | Complies | |
Particle Size | 100% pass 80 mesh | Complies | |
Oder | Characteristic | Complies | |
Taste | Characteristic | Complies | |
Loss on Drying | ≤5.0% | 2.20% | |
Residue on Ignition | ≤0.1% | 0.05% | |
Residual | ≤0.1% | Complies | |
Residual Ethanol | ≤0.5% | Complies | |
Heave Mentals | ≤10ppm | Complies | |
Na | ≤0.1% | <0.1% | |
Pb | ≤3 ppm | Complies | |
Total Plate | <1000CFU/g | Complies | |
Yeast & Mold | <100 CFU /g | Complies | |
E. Coli | Negative | Complies | |
Salmonella | Negative | Complies |